Inside the research
Universal Health Services, Inc.
UHS Research profile · latest available data
Price overview
$178.86
▲ +1.87 (+1.1%)
| 52w hi | $243.12 |
|---|---|
| 52w lo | $141.00 |
| Vol | 643.80K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.05
| Short | -0.23 |
|---|---|
| Medium | +0.15 |
| Long | +0.39 |
computed 2026-09-27
Key fundamentals
Universal Health Services, Inc.
Healthcare · Medical Care Facilities
| Market cap | $10.54B |
|---|---|
| Enterprise value | $15.81B |
| Trailing P/E | 7.30x |
| Forward P/E | 7.45x |
| EV / EBITDA | 5.86x |
| P / S (ttm) | 0.58x |
| Profit margin | 8.4% |
| Return on equity | 20.9% |
| Revenue growth | +8.3% |
| Earnings growth | +10.1% |
| Debt / equity | 68.74 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.32 | |
| Sector | +0.08 | |
| Technical | -0.13 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Risk Metrics
| Beta vs SPX | 0.51 |
|---|---|
| Corr SPX | 0.24 |
| Annual vol | 33.4% |
| Annual ret | -8.6% |
| Sharpe | -0.26 |
| Max DD | -42.2% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $223.31 |
|---|---|
| High / Low | $310.00 / $190.00 |
| Median | $215.00 |
| Analysts | 16 |
| Strong Buy | 2 | |
|---|---|---|
| Buy | 6 | |
| Hold | 10 | |
| Sell | 0 | |
| Strong Sell | 1 |
Recent rating actions
| 2026-04-30 | UBS | → Buy |
| 2026-04-29 | TD Cowen | → Buy |
| 2026-04-29 | RBC Capital | → Sector Perform |
| 2026-04-29 | Guggenheim | → Buy |
| 2026-04-29 | Cantor Fitzgerald | → Neutral |
| 2026-04-29 | Baird | → Neutral |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-13 | Material Agreement, Exhibits | read |
| 2026-07-28 | Earnings Release, Exhibits | read |
| 2026-07-21 | Material Agreement, Material Obligation… | read |
| 2026-05-22 | Shareholder Vote | read |
| 2026-05-21 | Officer / Director Change | read |
| 2026-04-28 | Earnings Release, Exhibits | read |
| 2026-04-24 | Material Agreement, Material Obligation… | read |
| 2026-03-30 | Officer / Director Change | read |
| 2026-03-09 | Other Material Event, Exhibits | read |
| 2026-02-26 | Earnings Release, Other Material Event… | read |
| 2025-12-31 | Officer / Director Change, Exhibits | read |
| 2025-10-28 | Earnings Release, Exhibits | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-27 | MILLER ALAN B | Executive Chairman | J | 13.96K | — |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | J | 9.42K | — |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | J | 14.16K | — |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | J | 50.99K | — |
| 2026-05-27 | MILLER ALAN B | Executive Chairman | J | 25.50K | — |
| 2026-05-20 | Chen-Langenmayr Nina | Grant | 1.22K | — | |
| 2026-05-20 | SUSSMAN ELLIOT J MD MBA | Grant | 1.22K | — | |
| 2026-05-20 | McDonnell Eileen C. | Grant | 1.22K | — | |
| 2026-05-20 | Singer Maria Ruderman | Grant | 1.22K | — | |
| 2026-05-20 | Nimetz Warren J. | Grant | 1.22K | — |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 0 |
| Top-5 share | 0.0% |
| HHI | 0 (—) |
Dividends
| Yield (TTM) | 0.22% |
|---|---|
| $ / share (TTM) | $0.40 |
| 5y CAGR | +32.0% |
Annual dividend per share
| 2021 | $0.80 |
|---|---|
| 2022 | $0.80 |
| 2023 | $0.80 |
| 2024 | $0.80 |
| 2025 | $0.80 |
| 2026 | $0.20 |
SEC Filings
The Long Run
FY 2010–2025 · 16 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $17.36B | +20.1% | |
| Operating income | $1.18B | +7.3% | |
| Net income | $1.49B | +12.3% | |
| Cash from ops | $1.27B | +5.8% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $176.99 | $180.41 | $176.54 | $178.86 | 643.80K |
| Sep 24 | $182.51 | $184.88 | $176.67 | $176.99 | 890.40K |
| Sep 23 | $179.51 | $186.06 | $179.09 | $181.39 | 896.20K |
| Sep 22 | $176.24 | $181.58 | $176.20 | $179.29 | 797.70K |
| Sep 21 | $176.61 | $180.02 | $174.22 | $174.74 | 924.60K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →